Results 261 to 263 of about 36,119 (263)

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet Oncology, The, 2019
Michael Fx Gnant, Richard F Greil, Florian Fitzal   +2 more
exaly  

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

New England Journal of Medicine, 2009
Steven Cummings, Michael McClung, Richard Eastell   +2 more
exaly  

Managing bone metastases and reducing skeletal related events in prostate cancer

Nature Reviews Clinical Oncology, 2014
Fred Saad
exaly